GHISONI, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 2.434
EU - Europa 1.646
AS - Asia 1.347
SA - Sud America 69
OC - Oceania 37
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 6
Totale 5.565
Nazione #
US - Stati Uniti d'America 2.337
CN - Cina 696
IT - Italia 472
GB - Regno Unito 256
SG - Singapore 150
DE - Germania 133
FR - Francia 131
IE - Irlanda 123
JP - Giappone 117
PL - Polonia 94
ES - Italia 90
IN - India 85
SE - Svezia 85
CA - Canada 72
VN - Vietnam 61
FI - Finlandia 42
KR - Corea 40
AU - Australia 37
TR - Turchia 35
NL - Olanda 34
BR - Brasile 33
TW - Taiwan 29
HK - Hong Kong 26
BE - Belgio 24
MX - Messico 24
ID - Indonesia 23
UA - Ucraina 21
AT - Austria 20
CH - Svizzera 19
TH - Thailandia 17
IL - Israele 16
IR - Iran 15
PT - Portogallo 15
PE - Perù 13
DK - Danimarca 12
GR - Grecia 12
HU - Ungheria 11
RO - Romania 11
RU - Federazione Russa 10
CO - Colombia 9
CZ - Repubblica Ceca 8
SA - Arabia Saudita 8
CL - Cile 6
NO - Norvegia 6
TN - Tunisia 6
AR - Argentina 5
KW - Kuwait 5
MY - Malesia 5
AP - ???statistics.table.value.countryCode.AP??? 4
EG - Egitto 4
MA - Marocco 4
UZ - Uzbekistan 4
AM - Armenia 3
BG - Bulgaria 3
EC - Ecuador 3
HR - Croazia 3
LT - Lituania 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
PK - Pakistan 3
RS - Serbia 3
SD - Sudan 3
ZA - Sudafrica 3
BF - Burkina Faso 2
BY - Bielorussia 2
EU - Europa 2
JO - Giordania 2
BD - Bangladesh 1
CU - Cuba 1
EE - Estonia 1
IQ - Iraq 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
PH - Filippine 1
QA - Qatar 1
Totale 5.565
Città #
Chandler 246
Fairfield 205
Ashburn 125
Santa Clara 120
Dublin 113
Singapore 109
Houston 104
Woodbridge 103
Beijing 96
Seattle 91
Ann Arbor 89
Cambridge 81
Wilmington 80
Redwood City 78
Shanghai 67
Torino 63
Guangzhou 44
Nanjing 43
Milan 40
Nyköping 39
Warsaw 39
London 32
New York 32
Columbus 30
Fremont 30
Dong Ket 28
Tokyo 27
Medford 26
Rome 26
Hangzhou 25
Helsinki 25
Pisa 25
Princeton 24
Boardman 23
Los Angeles 23
Jakarta 22
Dearborn 21
Jacksonville 21
Delhi 19
Wuhan 19
Taipei 17
Turin 17
Chengdu 16
Jinan 16
San Diego 14
Barcelona 13
Chicago 12
Munich 12
Ottawa 12
Gothenburg 11
Poznan 11
Tianjin 11
Vienna 11
Villeurbanne 11
Changsha 10
Harbin 10
São Paulo 10
Zhengzhou 10
Boston 9
Kunming 9
Madrid 9
Qingdao 9
Seoul 9
St Louis 9
Xian 9
Basingstoke 8
Birmingham 8
Central District 8
Duncan 8
Glasgow 8
Hanamkonda 8
Hanoi 8
Hong Kong 8
Naples 8
Valencia 8
Washington 8
Amsterdam 7
Ankara 7
Bangkok 7
Berlin 7
Bologna 7
Brasília 7
Brussels 7
Copenhagen 7
Hamburg 7
Lima 7
Manchester 7
Nanchang 7
Oxford 7
Philadelphia 7
Riverton 7
Shenyang 7
Sydney 7
Toronto 7
Changchun 6
Chiyoda-ku 6
Deatsville 6
Dresden 6
Flushing 6
Freiburg 6
Totale 2.990
Nome #
PARP Inhibitors in Ovarian Cancer 2.685
Checkpoint inhibitors in endometrial cancer: Preclinical rationale and clinical activity 238
Androgen receptor status predicts development of brain metastases in ovarian cancers 203
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018 193
Deficiencies in health-related quality of life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016 168
Are cyclin-dependent kinases 4/6 inhibitors ready for prime time in estrogen-receptor positive metastatic breast cancer? 149
A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience 136
Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer 135
TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers 130
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience 128
Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications 126
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy 124
Reprogramming T-cells for adoptive immunotherapy of ovarian cancer 119
Immune checkpoint inhibitors in epithelial ovarian cancer: An overview on efficacy and future perspectives 111
Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series 108
Assays of conventional chemotherapeutics and targeted drugs for ovarian cancer using patient derived models 103
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018 103
Ovarian cancer immunotherapy: Turning up the heat 93
Role of cyclin-dependent kinase inhibitors in endometrial cancer 84
Women with synchronous or metachronous lung and ovarian cancer: A multi-institutional report 81
Role of Mediterranean diet in preventing platinum based gastrointestinal toxicity in gynecolocological malignancies: A single Institution experience 80
Safe Use of Carfilzomib in a Patient with Multiple Myeloma and Intermittent Type 1 Brugada ECG Pattern: A Case Report 79
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018 69
Veliparib: a new therapeutic option in ovarian cancer? 66
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers 66
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study 41
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience 27
763P Treatment response to non-platinum therapies in ovarian cancer patients according to BRCA status: A retrospective analysis of a large multicentric cohort 9
Totale 5.654
Categoria #
all - tutte 12.856
article - articoli 0
book - libri 0
conference - conferenze 312
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.168


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020321 0 0 0 0 0 46 45 48 61 40 31 50
2020/20211.251 31 79 151 118 108 109 89 105 99 120 84 158
2021/20221.125 88 72 63 89 91 93 102 106 89 79 142 111
2022/20231.100 87 87 55 81 110 173 90 95 130 53 77 62
2023/2024935 93 118 45 86 81 77 70 62 26 100 75 102
2024/2025530 34 41 56 84 227 88 0 0 0 0 0 0
Totale 5.654